Leef Brands (LEEEF) Other Accumulated Expenses (2024 - 2026)

Leef Brands (LEEEF) posted Other Accumulated Expenses of $1.4 million for Q1 2026, down 25.71% sequentially from $1.9 million in Q4 2025.

Leef Brands (LEEEF) Other Accumulated Expenses (2024 - 2026) Analysis & Trends

Leef Brands has reported Other Accumulated Expenses for 3 years, with the latest figure at $1.4 million in Q1 2026.

Quarterly Other Accumulated Expenses changed N/A year-over-year to $1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.4 million (changed N/A YoY) and the FY2025 annual result came in at $1.9 million, up 28.74% from the prior year.
Other Accumulated Expenses fell to $1.4 million in Q1 2026 per LEEEF's latest filing, from $1.9 million in the prior quarter.
Over five years, Other Accumulated Expenses peaked at $1.9 million in Q4 2025 and troughed at $1.4 million in Q1 2026.
A 3-year average of $1.6 million and a median of $1.5 million in 2024 frame the typical range for Other Accumulated Expenses.
The widest YoY moves for Other Accumulated Expenses: up 28.74% in 2025, down 28.74% in 2025.
Over 3 years, Other Accumulated Expenses stood at $1.5 million in 2024, then grew by 28.74% to $1.9 million in 2025, then decreased by 25.71% to $1.4 million in 2026.
According to Business Quant data, Other Accumulated Expenses over the past three periods registered $1.4 million, $1.9 million, and $1.5 million for Q1 2026, Q4 2025, and Q4 2024 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	43.83 Bn	42.86 Bn	-
2	Teva Pharmaceutical Industries	42.87 Bn	39.22 Bn	2.15 Bn
3	Zoetis	31.41 Bn	29.73 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.55 Bn	22.75 Bn	5.10 Bn
5	United Therapeutics	22.08 Bn	19.42 Bn	683.80 Mn
6	Viatris	18.73 Bn	17.84 Bn	1.46 Bn
7	Neurocrine Biosciences	15.44 Bn	15.05 Bn	935.80 Mn
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.11 Bn	9.94 Bn	-
10	Leef Brands	59.45 Mn	54.50 Mn	2.41 Mn

Download Data